P2X7 — P2X Purinoceptor 7
Pathway Diagram
flowchart TD
P2X7["P2X7"]
style P2X7 fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0
NLRP3_Inflammasome["NLRP3 Inflammasome"]
P2X7 -->|"activates"| NLRP3_Inflammasome
Apoptosis["Apoptosis"]
P2X7 -->|"activates"| Apoptosis
ATP["ATP"]
P2X7 -->|"expressed in"| ATP
Als["Als"]
P2X7 -->|"associated with"| Als
Ms["Ms"]
P2X7 -->|"associated with"| Ms
Diabetes["Diabetes"]
P2X7 -->|"associated with"| Diabetes
Aging["Aging"]
P2X7 -->|"expressed in"| Aging
P2X7 -->|"activates"| Ms
Extracellular_ATP["Extracellular ATP"]
Extracellular_ATP -->|"binds"| P2X7
APOPTOSIS["APOPTOSIS"]
APOPTOSIS -->|"activates"| P2X7
style NLRP3_Inflammasome fill:#5d4400,stroke:#4fc3f7,color:#e0e0e0
style Apoptosis fill:#5d4400,stroke:#4fc3f7,color:#e0e0e0
style ATP fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0
style Als fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0
style Ms fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0
style Diabetes fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0
style Aging fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0
style Extracellular_ATP fill:#006494,stroke:#4fc3f7,color:#e0e0e0
style APOPTOSIS fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0
Overview
...P2X7 — P2X Purinoceptor 7
Pathway Diagram
Mermaid diagram (expand to render)
Overview
P2X7 (P2X receptor 7) is an ATP-gated ion channel encoded by the P2RX7 gene located on chromosome 12q24.31. It plays a critical role in neuroinflammation and is implicated in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), multiple sclerosis, and other neurodegenerative disorders. Unlike other P2X receptors, P2X7 exhibits unique pharmacological and functional properties that make it a compelling therapeutic target.
The P2X7 receptor is primarily expressed on immune cells, particularly [microglia](/cell-types/microglia-neuroinflammation) in the central nervous system, where it functions as a sentinel for extracellular ATP released during cellular stress, tissue damage, or pathological conditions. Activation of P2X7 triggers a cascade of pro-inflammatory events that, when chronic, contribute to neurotoxicity and disease progression. [@receptor2020]
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">P2X7 Receptor</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>P2RX7</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>12q24.31</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>10029</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>Q99572</td></tr>
<tr><td><strong>Protein Length</strong></td><td>595 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~66 kDa (monomer), ~200 kDa (trimer)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>P2X receptor family (ligand-gated ion channels)</td></tr>
<tr><td><strong>Ligand</strong></td><td>Extracellular ATP (EC₅₀ ~100-300 μM)</td></tr>
<tr><td><strong>Expression</strong></td><td>High: microglia. Moderate: astrocytes, neurons</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">89 edges</a></td>
</tr>
</table>
</div>
Gene and Protein Structure
P2RX7 Gene Organization
The P2RX7 gene spans approximately 54 kb and consists of 17 exons. Multiple alternatively spliced isoforms have been identified, including variants with altered trafficking or function. Single nucleotide polymorphisms (SNPs) in P2RX7 have been extensively studied for their association with inflammatory and neurodegenerative diseases. [@sevigny2017]
Protein Architecture
P2X7 is a trimeric ligand-gated ion channel with a unique structure:
Extracellular Domain (~280 aa): Contains the ATP-binding site with conserved glutamate residues critical for ligand recognition. The extracellular loop contains multiple cysteine residues forming disulfide bonds that stabilize the structure.
Transmembrane Domains (TM1, TM2): Two α-helical transmembrane segments that form the channel pore. TM2 contains a hydrophobic segment that lines the ion channel.
Intracellular N- and C-termini: The C-terminal tail (~220 aa) is critical for channel function, containing motifs for:
- Protein-protein interactions
- Phosphorylation sites
- Palmitoylation sites
- Interaction with the actin cytoskeleton
The P2X7 receptor exhibits a distinctive "pannexin-1 hemichannel" mode of signaling where prolonged ATP activation leads to formation of a large pore capable of passing molecules up to 900 Da, independent of the ion channel function.
Normal Physiological Functions
ATP Signaling and Purinergic Signaling
Under physiological conditions, extracellular ATP concentrations are maintained at nanomolar levels through the coordinated action of ectonucleotidases (CD39, CD73) and ATP-release mechanisms. P2X7 acts as a danger sensor, responding to the ATP surge that occurs during:
- Cellular stress or injury
- Pathogen invasion
- Tissue damage
- Inflammation
The receptor exhibits low affinity for ATP (EC₅₀ ~100-300 μM), meaning it requirespathological ATP release to activate, distinguishing it from other P2X receptors that respond to physiological ATP concentrations.
Immune Cell Activation
In immune cells, P2X7 activation triggers:
- NLRP3 inflammasome assembly: P2X7 activation provides signal 1 (priming) and signal 2 (activation) for NLRP3 inflammasome formation [@nlrp2020]
- IL-1β processing and release: Pro-IL-1β is cleaved by caspase-1 activated through NLRP3 inflammasome signaling
- Pyroptosis: In some contexts, P2X7 activation triggers gasdermin D-mediated pyroptotic cell death
- Phospholipid scrambling: Activation leads to phosphatidylserine exposure on cell surfaces
Tissue Homeostasis
In non-neuronal tissues, P2X7 participates in:
- Wound healing and tissue repair
- Immune surveillance
- Cell proliferation and differentiation
- Bone remodeling
Role in Neuroinflammation
P2X7 is centrally positioned at the intersection of ATP release, microglial activation, and neuroinflammation. In the CNS, microglia express high levels of P2X7 and serve as the primary responders to extracellular ATP released from damaged [neurons](/entities/neurons), activated astrocytes, or themselves. [@neuroinflammation2019]
Microglial Activation
P2X7 on microglia mediates:
Morphological transformation: From ramified resting to amoeboid activated state
Cytokine production: IL-1β, IL-6, TNF-α, IL-18
Chemokine production: CCL2, CXCL10
Reactive oxygen species (ROS) production: Through NADPH oxidase activation
Nitric oxide (NO) production: Via inducible nitric oxide synthase (iNOS)
Phagocytosis modulation: Enhanced phagocytic activity in early stagesAstrocyte-Neuron Communication
P2X7 on astrocytes responds to neuronal ATP release and:
- Modulates astrocyte reactivity
- Regulates glutamate uptake and release
- Influences blood-brain barrier integrity
- Coordinates neuroinflammatory responses
Role in Alzheimer's Disease
In Alzheimer's disease (AD), P2X7 contributes to multiple pathological processes:
Amyloid-beta and P2X7
- Elevated P2X7 expression in [microglia](/cell-types/microglia-neuroinflammation) surrounding amyloid plaques [@receptor2020]
- Aβ peptides directly activate P2X7 through ATP release from cells
- P2X7 activation promotes further amyloidogenic APP processing
- Genetic variants in P2RX7 associated with increased AD risk
Tau Pathology and P2X7
P2X7 influences [tau](/proteins/tau) pathology through:
- NLRP3 inflammasome activation leading to increased tau phosphorylation
- IL-1β release promoting tau pathology spread
- Regulation of tau secretion and propagation [@riquelme2021]
Synaptic Dysfunction
- P2X7 activation contributes to synaptic loss
- Promotes excessive glutamate release from glia
- Contributes to excitotoxicity through dysregulated calcium signaling
- Impairs synaptic plasticity mechanisms
Therapeutic Implications for AD
P2X7 antagonists show promise in AD models:
- Brilliant Blue G (BBG) reduces amyloid plaque burden
- A-438079 improves cognitive function in AD mice
- P2X7 deletion protects against Aβ-induced memory deficits
- Combined anti-inflammatory and anti-amyloid approaches
Role in Parkinson's Disease
In Parkinson's disease (PD), P2X7 plays a critical role in dopaminergic neuron degeneration: [@parkinsons2021]
Microglial Activation in Substantia Nigra
- P2X7 highly expressed in substantia nigra microglia
- ATP released from damaged dopaminergic [neurons](/cell-types/dopaminergic-neurons) triggers microglial activation
- Chronic P2X7 activation leads to neurotoxic phenotype
- P2X7 blockade protects dopaminergic neurons [@martinez2020]
Alpha-synuclein and P2X7
P2X7 interacts with [alpha-synuclein](/proteins/alpha-synuclein) pathology:
- P2X7 activation promotes α-synuclein aggregation
- α-Synuclein can activate P2X7 on microglia
- NLRP3 inflammasome links α-synuclein to neuroinflammation
- P2X7 antagonism reduces α-synuclein pathology in models [@yang2022]
Mitochondrial Dysfunction
- P2X7 activation contributes to mitochondrial dysfunction
- Loss of mitochondrial membrane potential
- Increased ROS production
- Impaired mitophagy
Therapeutic Strategies for PD
P2X7-targeted approaches:
- BBG protects dopaminergic neurons in MPTP models
- P2X7 knockout mice resistant to MPTP toxicity
- Antagonists reduce microglial activation and rescue neurons
- Blood-brain barrier penetration remains a challenge
Role in Amyotrophic Lateral Sclerosis
In ALS, P2X7 contributes to motor neuron degeneration: [@chen2020]
Microglial P2X7 in ALS
- Upregulated P2X7 in ALS microglia
- Activated microglia release toxic factors
- P2X7-mediated inflammation accelerates motor neuron death
- Genetic variants affect ALS susceptibility
TDP-43 Pathology
- P2X7 interacts with TDP-43 proteinopathy
- NLRP3 inflammasome activation in ALS
- Links between RNA metabolism and inflammation
Therapeutic Targeting in ALS
- P2X7 antagonists protect motor neurons
- Combined approaches targeting multiple pathways
- Early intervention may be critical
Role in Multiple Sclerosis
P2X7 is implicated in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE): [@engelhardt2022]
- P2X7 expressed on infiltrating immune cells
- Promotes myelin-specific T cell activation
- Contributes to demyelination
- P2X7 blockade ameliorates EAE
Autophagy and P2X7
P2X7 regulates [autophagy](/mechanisms/autophagy), a critical process in neurodegeneration: [@he2021]
- P2X7 activation modulates autophagy flux
- Dysregulated autophagy contributes to protein aggregation
- P2X7-NLRP3 axis affects mitophagy
- Therapeutic modulation of autophagy shows promise
Expression Pattern in the Brain
| Cell Type | Expression Level | Key Functions |
|-----------|------------------|---------------|
| Microglia | High | Primary immune sensor, inflammasome activation |
| Astrocytes | Moderate | Neuroinflammation coordination |
| Neurons | Low-Moderate | ATP sensing, calcium signaling |
| Oligodendrocytes | Low | Myelin maintenance |
Therapeutic Targeting
P2X7 Antagonists
Several P2X7 antagonists have been developed:
| Compound | Specificity | Stage | Notes |
|----------|--------------|-------|-------|
| Brilliant Blue G (BBG) | Non-selective | Preclinical | FDA-approved for some uses, BBB penetration |
| A-438079 | Selective | Preclinical | Anti-inflammatory effects |
| A-740003 | Selective | Preclinical | Neuroprotective in models |
| AZD9056 | Selective | Clinical trials | Tested for inflammatory diseases |
| CE-224535 | Selective | Clinical trials | Rheumatoid arthritis |
Challenges in CNS Drug Development
- Blood-brain barrier penetration: Many P2X7 antagonists do not cross the BBB
- Peripheral vs. central effects: Distinguishing central vs. peripheral P2X7 actions
- Dosing: Chronic dosing required for neurodegenerative diseases
- Safety: Immune suppression concerns with long-term use
Emerging Approaches
- Brain-penetrant antagonists: New molecules with improved BBB penetration
- Allosteric modulators: Targeting distinct binding sites
- Nanoparticle delivery: Targeted CNS delivery
- Gene therapy: Viral vector-mediated delivery
Genetic Variants and Disease Risk
P2RX7 polymorphisms have been associated with:
- Alzheimer's disease: Multiple SNPs affect risk
- Parkinson's disease: Some variants increase susceptibility
- Multiple sclerosis: Genetic associations identified
- Inflammatory disorders: Rheumatoid arthritis, Crohn's disease
These genetic findings support P2X7 as a therapeutic target.
Diagnostic and Biomarker Potential
- P2X7 expression may serve as biomarker for neuroinflammation
- PET ligands for P2X7 in development
- Cerebrospinal fluid IL-1β as downstream marker
- Peripheral blood monocyte P2X7 as accessible marker
- [NLRP3 Inflammasome](/mechanisms/nlrp3-inflammasome)
- [Microglia](/cell-types/microglia-neuroinflammation)
- [IL-1β](/proteins/il1b-protein)
- [Alpha-synuclein](/proteins/alpha-synuclein)
- [Tau Protein](/proteins/tau)
- [Amyloid-beta](/proteins/amyloid-beta)
- [NF-κB Signaling](/mechanisms/nf-kb-signaling)
- [Autophagy](/mechanisms/autophagy)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/als)
Key Publications
[P2X7 receptor in Alzheimer's disease (2020)](https://doi.org/10.1016/j.neuropharm.2020.108123)
[P2X7 and neuroinflammation (2019)](https://doi.org/10.1111/jnc.14738)
[P2X7 in Parkinson's disease (2021)](https://doi.org/10.1007/s00401-021-02276-3)
[NLRP3 inflammasome and P2X7 signaling (2020)](https://doi.org/10.1016/j.tips.2020.03.008)
[P2X7 as therapeutic target in neurodegeneration (2022)](https://doi.org/10.1016/j.pharmthera.2022.108267)
[P2X7 receptor: a new neuroprotective target (2015)](https://pubmed.ncbi.nlm.nih.gov/26149747/)
[P2X7 in multiple sclerosis (2022)](https://pubmed.ncbi.nlm.nih.gov/35193345/)
[The P2X7 receptor in extracellular ATP signaling (2017)](https://pubmed.ncbi.nlm.nih.gov/28632473/)
[Brilliant Blue G as P2X7 antagonist (2021)](https://pubmed.ncbi.nlm.nih.gov/33445567/)
[P2X7 and α-synuclein in Parkinson's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)References
[P2X7 receptor in Alzheimer's disease, Neuropharmacology (2020)](https://doi.org/10.1016/j.neuropharm.2020.108123)
[P2X7 and neuroinflammation, J Neurochem (2019)](https://doi.org/10.1111/jnc.14738)
[P2X7 in Parkinson's disease, Acta Neuropathol (2021)](https://doi.org/10.1007/s00401-021-02276-3)
[NLRP3 inflammasome and P2X7 signaling, Trends Pharmacol Sci (2020)](https://doi.org/10.1016/j.tips.2020.03.008)
[P2X7 as therapeutic target in neurodegeneration, Pharmacol Ther (2022)](https://doi.org/10.1016/j.pharmthera.2022.108267)
[P2X7 receptor: a new neuroprotective target, Front Neurol (2015)](https://pubmed.ncbi.nlm.nih.gov/26149747/)
[P2X7 in multiple sclerosis, J Neuroinflammation (2022)](https://pubmed.ncbi.nlm.nih.gov/35193345/)
[The P2X7 receptor joins the extracellular ATP signaling network, Pflugers Arch (2017)](https://pubmed.ncbi.nlm.nih.gov/28632473/)
[Brilliant Blue G as P2X7 antagonist, Front Cell Neurosci (2021)](https://pubmed.ncbi.nlm.nih.gov/33445567/)
[P2X7 and α-synuclein interplay, J Parkinsons Dis (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/als)
- [Multiple Sclerosis](/diseases/multiple-sclerosis)
- [Microglia](/cell-types/microglia-neuroinflammation)
- [Neuroinflammation](/mechanisms/neuroinflammation)
- [Inflammasome Signaling](/mechanisms/inflammasome-signaling)
External Links
- [NCBI Gene: P2RX7](https://www.ncbi.nlm.nih.gov/gene/10029)
- [UniProt: Q99572](https://www.uniprot.org/uniprot/Q99572)
- [IUPHAR Database: P2X7](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=442)
- [KEGG Pathway: P2X7 signaling](https://www.genome.jp/kegg/pathway.html)
Pathway Diagram
The following diagram shows the key molecular relationships involving P2X7 — P2X Purinoceptor 7 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)